Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06635902
What this trial is testing

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Suvankar Majumdar 99
Not applicableUnknownNCT02946866
What this trial is testing

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

Who this might be right for
Cerebral Cavernous MalformationIntracerebral Hemorrhage
Seoul National University Hospital 228
Not applicableStudy completedNCT03824522
What this trial is testing

Post Marketing Surveillance Study for ADYNOVATE in South Korea

Who this might be right for
Hemophilia A
Takeda 341
Testing effectiveness (Phase 2)Looking for participantsNCT03214354
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Who this might be right for
Sickle Cell DiseaseStem Cell Transplant ComplicationsRed Blood Cell Disorder+1 more
University of Calgary 12
Not applicableUnknownNCT03498105
What this trial is testing

Utility of the Cardiac Electrical BiomarkerDisease

Who this might be right for
Acute Chest Syndrome
Joanne Turner 800
Not applicableStudy completedNCT05345561
What this trial is testing

Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

Who this might be right for
Fetal and Neonatal Alloimmune Thrombocytopenia
Rallybio 14,390
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)Ended earlyNCT04832139
What this trial is testing

Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Who this might be right for
Healthy Volunteers
Pfizer 22
Post-approval studies (Phase 4)Study completedNCT03992001
What this trial is testing

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

Who this might be right for
Thalassemia Major
Università degli Studi di Ferrara 55
Testing effectiveness (Phase 2)Study completedNCT00062075
What this trial is testing

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
National Cancer Institute (NCI) 47
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Not applicableWithdrawnNCT00770419
What this trial is testing

Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more
Rutgers, The State University of New Jersey
Early research (Phase 1)Study completedNCT02083965
What this trial is testing

Pharmacokinetics of rFVIIIFc at Two Vial Strengths

Who this might be right for
Severe Hemophilia A
Bioverativ Therapeutics Inc. 19
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Not applicableNot Yet RecruitingNCT07674277
What this trial is testing

Virtual Reality for SCD VOC

Who this might be right for
Sickle Cell Disease
University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06253507
What this trial is testing

PCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

Who this might be right for
p47Autosomal RecessiveChronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Next Page